vs
Penumbra Inc（PEN）与Rackspace Technology, Inc.（RXT）财务数据对比。点击上方公司名可切换其他公司
Rackspace Technology, Inc.的季度营收约是Penumbra Inc的1.8倍（$682.8M vs $385.4M），Penumbra Inc净利率更高（12.3% vs -4.8%，领先17.1%），Penumbra Inc同比增速更快（22.1% vs -0.4%），Penumbra Inc自由现金流更多（$68.0M vs $56.0M），过去两年Penumbra Inc的营收复合增速更高（17.6% vs -0.6%）
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
Rackspace Technology, Inc.是总部位于美国得克萨斯州圣安东尼奥的云计算企业，在弗吉尼亚州雷斯顿以及澳大利亚、加拿大、英国、印度、迪拜、瑞士、荷兰、德国、新加坡、墨西哥、中国香港等多个国家和地区设有办事处，数据中心分布于全球多个主要城市，为客户提供专业的云计算相关服务。
PEN vs RXT — 直观对比
营收规模更大
RXT
是对方的1.8倍
$385.4M
营收增速更快
PEN
高出22.6%
-0.4%
净利率更高
PEN
高出17.1%
-4.8%
自由现金流更多
PEN
多$12.1M
$56.0M
两年增速更快
PEN
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $385.4M | $682.8M |
| 净利润 | $47.3M | $-32.7M |
| 毛利率 | 68.0% | 17.6% |
| 营业利润率 | 15.4% | -0.5% |
| 净利率 | 12.3% | -4.8% |
| 营收同比 | 22.1% | -0.4% |
| 净利润同比 | 40.6% | 41.6% |
| 每股收益（稀释后） | $1.20 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PENRXT
| Q4 25 | $385.4M | $682.8M | ||
| Q3 25 | $354.7M | $671.2M | ||
| Q2 25 | $339.5M | $666.3M | ||
| Q1 25 | $324.1M | $665.4M | ||
| Q4 24 | $315.5M | $685.6M | ||
| Q3 24 | $301.0M | $675.8M | ||
| Q2 24 | $299.4M | $684.9M | ||
| Q1 24 | $278.7M | $690.8M |
净利润PENRXT
| Q4 25 | $47.3M | $-32.7M | ||
| Q3 25 | $45.9M | $-67.1M | ||
| Q2 25 | $45.3M | $-54.5M | ||
| Q1 25 | $39.2M | $-71.5M | ||
| Q4 24 | $33.7M | $-56.0M | ||
| Q3 24 | $29.5M | $-186.6M | ||
| Q2 24 | $-60.2M | $25.0M | ||
| Q1 24 | $11.0M | $-640.6M |
毛利率PENRXT
| Q4 25 | 68.0% | 17.6% | ||
| Q3 25 | 67.8% | 19.4% | ||
| Q2 25 | 66.0% | 19.4% | ||
| Q1 25 | 66.6% | 19.1% | ||
| Q4 24 | 66.8% | 19.2% | ||
| Q3 24 | 66.5% | 20.3% | ||
| Q2 24 | 54.4% | 19.2% | ||
| Q1 24 | 65.0% | 19.2% |
营业利润率PENRXT
| Q4 25 | 15.4% | -0.5% | ||
| Q3 25 | 13.8% | -5.1% | ||
| Q2 25 | 12.0% | -3.8% | ||
| Q1 25 | 12.4% | -5.8% | ||
| Q4 24 | 13.6% | -4.2% | ||
| Q3 24 | 11.7% | -25.7% | ||
| Q2 24 | -27.0% | -7.9% | ||
| Q1 24 | 4.3% | -94.5% |
净利率PENRXT
| Q4 25 | 12.3% | -4.8% | ||
| Q3 25 | 12.9% | -10.0% | ||
| Q2 25 | 13.3% | -8.2% | ||
| Q1 25 | 12.1% | -10.7% | ||
| Q4 24 | 10.7% | -8.2% | ||
| Q3 24 | 9.8% | -27.6% | ||
| Q2 24 | -20.1% | 3.7% | ||
| Q1 24 | 3.9% | -92.7% |
每股收益（稀释后）PENRXT
| Q4 25 | $1.20 | $-0.13 | ||
| Q3 25 | $1.17 | $-0.28 | ||
| Q2 25 | $1.15 | $-0.23 | ||
| Q1 25 | $1.00 | $-0.31 | ||
| Q4 24 | $0.88 | $-0.20 | ||
| Q3 24 | $0.75 | $-0.82 | ||
| Q2 24 | $-1.55 | $0.11 | ||
| Q1 24 | $0.28 | $-2.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $186.9M | $105.8M |
| 总债务越低越好 | — | $2.7B |
| 股东权益账面价值 | $1.4B | $-1.2B |
| 总资产 | $1.8B | $2.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PENRXT
| Q4 25 | $186.9M | $105.8M | ||
| Q3 25 | $321.0M | $99.5M | ||
| Q2 25 | $421.8M | $103.9M | ||
| Q1 25 | $376.1M | $128.0M | ||
| Q4 24 | $324.4M | $144.0M | ||
| Q3 24 | $280.5M | $157.1M | ||
| Q2 24 | $288.3M | $190.2M | ||
| Q1 24 | $223.1M | $282.6M |
总债务PENRXT
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $3.0B |
股东权益PENRXT
| Q4 25 | $1.4B | $-1.2B | ||
| Q3 25 | $1.4B | $-1.2B | ||
| Q2 25 | $1.3B | $-1.1B | ||
| Q1 25 | $1.2B | $-1.1B | ||
| Q4 24 | $1.2B | $-1.0B | ||
| Q3 24 | $1.1B | $-949.7M | ||
| Q2 24 | $1.2B | $-756.2M | ||
| Q1 24 | $1.2B | $-787.2M |
总资产PENRXT
| Q4 25 | $1.8B | $2.8B | ||
| Q3 25 | $1.7B | $2.8B | ||
| Q2 25 | $1.7B | $2.9B | ||
| Q1 25 | $1.6B | $3.0B | ||
| Q4 24 | $1.5B | $3.1B | ||
| Q3 24 | $1.5B | $3.1B | ||
| Q2 24 | $1.5B | $3.4B | ||
| Q1 24 | $1.6B | $3.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $86.5M | $59.7M |
| 自由现金流经营现金流 - 资本支出 | $68.0M | $56.0M |
| 自由现金流率自由现金流/营收 | 17.7% | 8.2% |
| 资本支出强度资本支出/营收 | 4.8% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.83× | — |
| 过去12个月自由现金流最近4个季度 | $174.9M | $90.6M |
8季度趋势，按日历期对齐
经营现金流PENRXT
| Q4 25 | $86.5M | $59.7M | ||
| Q3 25 | $58.3M | $70.7M | ||
| Q2 25 | $44.9M | $8.4M | ||
| Q1 25 | $49.0M | $12.6M | ||
| Q4 24 | $51.1M | $54.3M | ||
| Q3 24 | $56.5M | $51.8M | ||
| Q2 24 | $22.6M | $24.1M | ||
| Q1 24 | $38.3M | $-90.3M |
自由现金流PENRXT
| Q4 25 | $68.0M | $56.0M | ||
| Q3 25 | $42.0M | $42.7M | ||
| Q2 25 | $29.4M | $-12.4M | ||
| Q1 25 | $35.5M | $4.3M | ||
| Q4 24 | $45.7M | $34.4M | ||
| Q3 24 | $51.0M | $27.3M | ||
| Q2 24 | $18.1M | $-14.5M | ||
| Q1 24 | $32.5M | $-118.4M |
自由现金流率PENRXT
| Q4 25 | 17.7% | 8.2% | ||
| Q3 25 | 11.8% | 6.4% | ||
| Q2 25 | 8.7% | -1.9% | ||
| Q1 25 | 11.0% | 0.6% | ||
| Q4 24 | 14.5% | 5.0% | ||
| Q3 24 | 16.9% | 4.0% | ||
| Q2 24 | 6.0% | -2.1% | ||
| Q1 24 | 11.7% | -17.1% |
资本支出强度PENRXT
| Q4 25 | 4.8% | 0.5% | ||
| Q3 25 | 4.6% | 4.2% | ||
| Q2 25 | 4.6% | 3.1% | ||
| Q1 25 | 4.2% | 1.2% | ||
| Q4 24 | 1.7% | 2.9% | ||
| Q3 24 | 1.8% | 3.6% | ||
| Q2 24 | 1.5% | 5.6% | ||
| Q1 24 | 2.1% | 4.1% |
现金转化率PENRXT
| Q4 25 | 1.83× | — | ||
| Q3 25 | 1.27× | — | ||
| Q2 25 | 0.99× | — | ||
| Q1 25 | 1.25× | — | ||
| Q4 24 | 1.52× | — | ||
| Q3 24 | 1.91× | — | ||
| Q2 24 | — | 0.96× | ||
| Q1 24 | 3.48× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
RXT
| Public Cloud Services Segment | $442.2M | 65% |
| Private Cloud Service Segment | $240.6M | 35% |
